Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS
Open Access
- 3 August 1991
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 338 (8762), 265-269
- https://doi.org/10.1016/0140-6736(91)90414-k
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Design Considerations for AIDS TrialsNew England Journal of Medicine, 1990
- A Pilot Study of Low-Dose Zidovudine in Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- Oral Therapy forPneumocystis cariniiPneumonia in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1990
- Aerosolized Pentamidine for Prophylaxis againstPneumocystis cariniiPneumoniaNew England Journal of Medicine, 1990
- Zidovudine in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- The Risk ofPneumocystis cariniiPneumonia among Men Infected with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990
- PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA RELAPSE BY PENTAMIDINE AEROSOL IN ZIDOVUDINE-TREATED AIDS PATIENTSThe Lancet, 1989
- THE MULTICENTER AIDS COHORT STUDY: RATIONALE, ORGANIZATION, AND SELECTED CHARACTERISTICS OF THE PARTICIPANTSAmerican Journal of Epidemiology, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Using observational data from registries to compare treatments: The fallacy of omnimetricsStatistics in Medicine, 1984